CNTY-813 is an iPSC-derived islet cell replacement therapy engineered with Allo-Evasion™ 5.0 for patients with type 1 diabetes; on track for IND submission in 4Q 2026 ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the ...

As cannabis legalization expands nationally, what should your patients with diabetes know about the risks and benefits?

Patients who undergo stepwise escalation often reach treatment failure more often.” He noted that combination therapy may be ...

New preclinical data on MS 001 in combination with semaglutide selected for ADA Late Breaking Poster Session and ...

Detailed price information for Structure Therapeutics Inc (GPCR-Q) from The Globe and Mail including charting and trades.

Damon Wayans speaks onstage during the 28th Annual Costume Designers Guild Awards at The Ebell of Los Angeles on February 12, ...

Diabetes Leadership Council (DLC), a patient advocacy organization dedicated to advancing patient-first policies at the local, state, and national levels, issued a timely call-to-action report on how ...

A 52% increase from baseline in mean C-peptide AUC at Week 12 in patients diagnosed within 0–3 years (n=5) receiving ...

On May 1, the state will become the first to require people on the government health program to fulfill a work requirement or ...

The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by ...

On Saturday, April 11, the Rome City-Brimfield Lions Club held their annual Diabetes Day service project. This community project focuses on the health of our local citizens. Miller's Super Valu hosted ...